imatinib

(redirected from Glivec)
Also found in: Medical.

i·mat·i·nib

 (ĭ-măt′ə-nĭb)
n.
A tyrosine kinase inhibitor, C29H31N7O, used in its mesylate form to treat certain types of leukemia and various other diseases.
Mentioned in ?
References in periodicals archive ?
Rose Ann is currently undergoing oral chemotherapy by taking Imatinib (Glivec) six times a day at P1,283 each.
Mother of 12-year-old leukemia patient appeals for help
While at Novartis, Boehm oversaw commercial launches of various oncology brands in the US and globally, such as Femara, Zometa and Glivec.
Nordic Nanovector's board of directors elects Rainer Boehm, MD as member
The dad of one, from Chelmsford, Essex, was treated with the drug Glivec, which was developed thanks to genetics work by Cancer Research UK.
'Research saved me'
Max had chemotherapy and a relatively new targeted treatment that stemmed from Cancer Research UK's underpinning research called Glivec.
Now Tough Mudder is next goal.
So we designed the study to test the effect of PPAR-[gamma] on the Hp-Hb-CD163 pathway through PPAR-[gamma] agonist monascin and its antagonist Glivec which mediates PPAR-[gamma] by declining the phosphorylation level [16] in a collagenase-induced ICH rat model.
PPAR-[gamma] Promotes Hematoma Clearance through Haptoglobin-Hemoglobin-CD163 in a Rat Model of Intracerebral Hemorrhage
When the patients were treated with the drug imatinib (Glivec), which blocks the effect of stem cell factor, the number of mature mast cells dropped, while the number of progenitor cells did not change.
New insight into how immune cells are formed
Even though Novartis won the case in court in 2012, they just started enforcing their imatinib patent in 2014, right after the government had regulated, for the second time in the previous 3 years, the price of Glivec, reducing it in about 11%.
Reflections on the report of the UN Secretary General's high level panel on access to medicines/Reflexoes sobre o relatorio do Secretario-Geral das Nacoes Unidas do painel de alto nivel em acesso a medicamentos
Novartis said on Tuesday that its net income from continuing operations had fallen by $50 million (45 million euros) from April to June this year because it was no longer the only company marketing a special cancer treatment, which it sells under the name Glivec.
Generic drug competition hits Novartis sales
Novartis' reorganization of its main drug unit, which accounts for about two-thirds of its $49 billion in annual sales, comes as it struggles with the patent expiration of blood cancer drug Glivec and slower-than-expected revenue from its new heart failure medicine, Entresto.
Novartis Splits Drugs Business As CEO Quits
The cost of the ailment was alleviated "a little bit" when he became one of hundreds of patients who received free medication (for trial) of glivec from Novartis (a pharmaceutical firm).
Cancer group coalition wins right to contest in Philippines poll

Dictionary browser ?
Full browser ?